… pharmaceuticals and cosmetics, which should enable the company to earn attractive returns on capital over the long haul. David Pyott , having held his position since 1998, follows as another long-serving CEO. Pyott previously headed the nutrition …
… objections, you may disconnect at this time. Thank you, Dory. Good morning. With me for today's conference call is David Pyott , Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance …
… objection, you may disconnect at this time. Thank you Mary Ann. Good morning. With me for today s conference call is David Pyott , Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance …
… objections, you may disconnect at this time. Thank you, Terri. Good morning. With me for today's conference call is David Pyott , Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance …
… objections, you may disconnect at this time. Thank you, Terri. Good morning. With me for today's conference call is David Pyott , Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance …
… objections, you may disconnect at this time. Thank you, Marian. Good morning. With me for today s conference call is David Pyott , Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance …
… 00 am ET Executives Scott Whitcup - Chief Scientific Officer and Executive Vice President of Research & Development David Pyott - Chairman, Chief Executive officer and President James Hindman - Senior Vice President, Treasury, Risk and Investor …
… objections, you may disconnect at this time. Thanks, Carrie. Good morning. With me for today's conference call is David Pyott , Chairman of the Board and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance and Business …
… Mad Money TV program, Monday May 23. CEO Interview: David Pyott , Allergan ( AGN ) Allergan ( AGN ) is no longer just ..... business has been lagging the rest of the segments, David Pyott expects to see the company's obesity treatments taking …
… Money TV Program, Wednesday May 4. CEO Interview: David Pyott , Allergan ( AGN ) While other healthcare stocks sold ..... bladder problems. On the increase in staff and R&D, David Pyott commented, "We believe in the long-term Complete …